Odanacatib Treatment Affects Trabecular and Cortical Bone in the Femur of Postmenopausal Women: Results of a Two-Year Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Odanacatib Treatment Affects Trabecular and Cortical Bone in the Femur of Postmenopausal Women: Results of a Two-Year Placebo-Controlled Trial

Published:2014-12-26 Issue:1 Volume:30 Page:30-38
ISSN:0884-0431
Container-title:Journal of Bone and Mineral Research
language:en
Short-container-title:J Bone Miner Res

Author:

Engelke Klaus¹²,Fuerst Thomas³,Dardzinski Bernard⁴,Kornak John⁵,Ather Shabana⁶,Genant Harry K⁷,de Papp Anne⁶

Affiliation:

1. Synarc Inc.; Hamburg Germany

2. Institute of Medical Physics; University of Erlangen; Erlangen Germany

3. Synarc Inc.; Newark CA USA

4. Department of Radiology, and Radiological Sciences; Uniformed Services University of Health Sciences (USUHS); Bethesda MD USA

5. Department of Epidemiology & Biostatistics; University of California; San Francisco CA USA

6. Merck & Co., Inc.; Whitehouse Station NJ USA

7. Department of Radiology; University of California; San Francisco CA USA

Funder

Merck & Co

ASBMR Annual Meeting

ECCEO Meeting

Publisher

Wiley

Subject

Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jbmr.2292/fullpdf

Reference15 articles.

1. its skeletal actions and role as a therapeutic target in osteoporosis;Costa;Nat Rev Rheumatol.,2011

2. Odanacatib, a cathepsin K inhibitor for the treatment of osteoporosis and other skeletal disorders associated with excessive bone remodeling;Lewiecki;IDrugs.,2009

3. Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study;Langdahl;J Bone Miner Res.,2012

4. Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect;Eisman;J Bone Miner Res.,2011

5. Odanacatib, a cathepsin-K inhibitor for osteoporosis: a two-year study in postmenopausal women with low bone density;Bone;J Bone Miner Res.,2010

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of odanacatib in the treatment of postmenopausal women with osteoporosis: a meta-analysis;Journal of Orthopaedic Surgery and Research;2024-08-29

2. Efficacy and safety of odanacatib for osteoporosis treatment: a systematic review and meta-analysis;Archives of Osteoporosis;2023-05-11

3. Study on Lipid-Lowering and Anti-Inflammatory Effects of Wild Mugwort (Mongolian Medicine TGLG-1) Based on LC-MS;Advances in Clinical Medicine;2023

4. ACR Appropriateness Criteria® Osteoporosis and Bone Mineral Density: 2022 Update;Journal of the American College of Radiology;2022-11

5. A patent review on cathepsin K inhibitors to treat osteoporosis (2011 – 2021);Expert Opinion on Therapeutic Patents;2022-03-10